Systemic lupus erythematosus (SLE) is an autoimmune combinational tissue ailment that primarily affects mothers of reproductive age. Autoantibodies and invulnerable complexes cause damage to a variety of means and tissues. Women with SLE can have intensification of disease before birth. SLE increases the risk of spontaneous abortion, preterm childbirth, intrauterine growth delay, preeclampsia, neonatal lupus, stillbirth, and intrauterine fetal cessation in pregnant women. The use of anticoagulants, steroids, and immunosuppressive powers during pregnancy poses a meaningful risk to both the mother and the unborn young. A multidisciplinary approach, in addition to close medical, obstetrical, and neonatal listening, results in the best possible effect. The authors describe the profitable management of an antenatal patient with certain antinuclear, anti-ds DNA, and antiphospholipid antibodies and a weak obstetric history. She had an crisis cesarean section and gave beginning to a healthy female infant.
Author(s) Details:
Avleen Kaur,
Department of Medicine, Maimonides Medical
Center, Brooklyn, NY, USA.
Karan
Deep Singh,
Government
Medical College, Amritsar, India.
Gurinder Mohan,
Department of Medicine, Siri Guru Ram Das University of Health and
Sciences, Amritsar, Punjab, India.
Karandeep Singh,
Department of Medicine, Government Medical College, Amritsar, Punjab,
India.
Umang
Khullar,
Department of Obstetrics and Gynecology, Siri
Guru Ram Das University of Health and Sciences, Amritsar, Punjab, India.
Please see the link here: https://stm.bookpi.org/RHDHR-V6/article/view/10285
No comments:
Post a Comment